Stocktoria
BridgeBio Oncology Therapeutics, Inc. BBOT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2024-02-09
BridgeBio Oncology Therapeutics, Inc. statistics & valuation
Market cap$592.8M
P / B1.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Return on assets | -29.9% | -45.2% | -12.5% |
| Return on equity | -32.6% | 41.6% | 0.0% |
| Current ratio | 12.34 | 8.10 | — |
Source: SEC EDGAR filings · CIK 0001869105 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.